Medical Devices Middle East

Middle East Nuclear Medicine Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Middle East Nuclear Medicine Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Middle East · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $542.4 Mn Placeholder estimate
Estimate 2025 $602.6 Mn 4.2% of the global market
Projected 2034 $1.55 Bn 157.9% Adds $951.4 Mn over 9 forecast years
CAGR 2025–2034 11.1% Faster than 64% of 193 Medical Devices markets here
Key players 6 +1
  • Middle East is 4.15% of the global market.
  • Among regions, the largest is North America at $7.20 Bn.
  • Fastest growing: Africa at 11.5% a year.
  • Middle East ranks 5th of 6 by size among regions.

Market size projection

Middle East

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$951.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Nuclear Medicine Market market size by year, Middle East
YearMarket sizeChange that yearSince 2025
2024 (estimate) $542.4 Mn — —
2025 (base) $602.6 Mn +$60.2 Mn —
2026 (forecast) $669.5 Mn +$66.9 Mn +11.1%
2027 (forecast) $743.8 Mn +$74.3 Mn +23.4%
2028 (forecast) $826.4 Mn +$82.6 Mn +37.1%
2029 (forecast) $918.1 Mn +$91.7 Mn +52.4%
2030 (forecast) $1.02 Bn +$101.9 Mn +69.3%
2031 (forecast) $1.13 Bn +$113.2 Mn +88.1%
2032 (forecast) $1.26 Bn +$125.8 Mn +108.9%
2033 (forecast) $1.40 Bn +$139.7 Mn +132.1%
2034 (forecast) $1.55 Bn +$155.3 Mn +157.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Middle East Nuclear Medicine Market Analysis at a glance
Market size, 2025$602.6 Mn placeholder estimate
Forecast, 2034$1.55 Bn placeholder estimate
Growth (CAGR), 2025–203411.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersGE Healthcare, Siemens Healthineers, Lantheus Holdings, Cardinal Health, Curium and 1 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Middle East Nuclear Medicine Market Analysis Executive Summary

Nuclear medicine uses small amounts of radioactive tracers and special cameras to see how organs work and to treat some cancers.

Key segments of the nuclear medicine market include product (SPECT Systems, PET Systems and Diagnostic Radiotracers) and application (Oncology, Cardiology and Neurology).

Bar chart: Middle East Nuclear Medicine market size, 2024–2034, placeholder estimates. $542.4 Mn in 2024, $602.6 Mn in 2025 and $1.55 Bn in 2034, 11.1% CAGR.
Middle East Nuclear Medicine market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Middle East Nuclear Medicine Market Dynamics

Market Growth Drivers

More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the nuclear medicine market. Clinicians also use imaging earlier in care.

Opportunity

AI-assisted reading, compact systems for clinics and the replacement of old scanners give the nuclear medicine market room to grow.

Market Restraints

High equipment prices, a shortage of trained staff and long replacement cycles in public hospitals hold back the nuclear medicine market.

Competitive Landscape for Nuclear Medicine Market in Middle East

The nuclear medicine market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Nuclear Medicine Market in Middle East

Nuclear Medicine in Middle East: rules and payment

In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)⁠[1], EDE (UAE)⁠[2], Ministry of Public Health (Qatar)⁠[3] and AMAR (Israel)⁠[4]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)⁠[5], mandatory health insurance (UAE)⁠[6], public care and compulsory insurance (Qatar)⁠[3] and four health funds (Israel)⁠[4].

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Emirates Drug Establishment. Checked 14 Nov 2026.

[3] Ministry of Public Health, Qatar. Checked 19 Nov 2026.

[4] Israel Ministry of Health. Checked 19 Nov 2026.

[5] Council of Health Insurance. Checked 14 Nov 2026.

[6] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how nuclear medicine products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.

Public data, with sources

Nuclear Medicine in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Nuclear Medicine market in Middle East?
Placeholder estimate: about $602.6 Mn in 2025, rising to about $1.55 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Nuclear Medicine market in Middle East growing?
Placeholder estimate: about 11.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Nuclear Medicine market report cover?
The report splits the market by product (SPECT Systems, PET Systems, Diagnostic Radiotracers, Therapeutic Radiopharmaceuticals), application (Oncology, Cardiology, Neurology, Thyroid Disease) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Nuclear Medicine market?
Key players include GE Healthcare, Siemens Healthineers, Lantheus Holdings, Cardinal Health, Curium and Bracco.
What is driving the Nuclear Medicine market?
More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the nuclear medicine market. Clinicians also use imaging earlier in care.
Back to Catalogue

Related Medical Devices reports in Middle East

See all

Related on imaging and oncology

See the topic